Chronic Obstructive Pulmonary Disease and Risk of Cutaneous T-cell Lymphoma: A Danish Population-based Cohort Study.

Authors:
Soerensen SBT; Nagy D; Ødum N; Iversen L; Lindahl LM.

Journal:
Acta Derm Venereol

Publication Year: 2023

DOI:
10.2340/actadv.v103.5238

PMCID:
PMC10461176

PMID:
37606154

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Derm Venereol

Abbreviation: Acta Derm Venereol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Sexually Transmitted Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Child with a Lump in the Neck: A Quiz.
Van Gysel D; Janmohamed SR; Locy H and 2 more (2024) - Transparency Score: 1/6
A Child with Hoarseness and Recurrent Cheek Erosions: A Quiz.
Song D; Wang S. (2024) - Transparency Score: 1/6
Adult Acne in Middle-age: Effects on Mental Health in General Population of the Northern Finland Bi…
Leskelä M; Jokelainen J; Huilaja L and 1 more (2024) - Transparency Score: 2/6
A Rare Case of Primary Cutaneous Basaloid Squamous Cell Carcinoma of the Finger.
Kim HS; Choi WG; Lee SK and 2 more (2024) - Transparency Score: 2/6
Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese P…
Numata T; Irisawa R; Mori M and 2 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest LI has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, AstraZeneca, BMS, Boehringer Ingelheim, Celgene, Centocor, Cilag, Eli Lilly, Janssen-Cilag, Kyowa Kirin, LEO Pharma, MSD, Novartis, Pfizer, Samsung, Sun Pharma and UCB."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025